ロード中...
A phase II multi-institutional study assessing simultaneous in-field boost helical tomotherapy for 1-3 brain metastases
BACKGROUND: Our research group has previously published a dosimetric planning study that demonstrated that a 60 Gy/10 fractions intralesional boost with whole-brain radiotherapy (WBRT) to 30 Gy/10 fractions was biologically equivalent with a stereotactic radiosurgery (SRS) boost of 18 Gy/1 fraction...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3341183/ https://ncbi.nlm.nih.gov/pubmed/22436144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-7-42 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|